Brain Imaging and Pain in Irritable Bowel Syndrome

NCT00065754 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2011-09-20

No results posted yet for this study

Summary

This study examines the mechanisms, including brain imaging of placebo analgesia

Conditions

  • Irritable Bowel Syndrome

Interventions

DRUG

placebo

Sponsors & Collaborators

  • National Center for Complementary and Integrative Health (NCCIH)

    collaborator NIH
  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH
  • University of Florida

    lead OTHER

Principal Investigators

  • Michael E Robinson, PhD · University of Florida

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-09-30
Primary Completion
2007-12-31
Completion
2007-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00065754 on ClinicalTrials.gov